التفاصيل البيبلوغرافية
| العنوان: |
JAK Inhibitors: 'A Valuable Addition' to the IBD Treatment Portfolio. |
| المؤلفون: |
Loftus Jr., Edward V.1 loftus.edward@mayo.edu |
| المصدر: |
Healio Gastroenterology. Oct2024, Vol. 10 Issue 10, p7-8. 2p. |
| مصطلحات موضوعية: |
*JANUS kinases, *ULCERATIVE colitis, *CROHN'S disease, *CARDIOVASCULAR diseases risk factors, *CANCER |
| مستخلص: |
An editorial focuses on the efficacy and safety of Janus kinase (JAK) inhibitors in treating ulcerative colitis and Crohn's disease, highlighting their rapid onset and effectiveness in patients who have previously failed other therapies. It discusses the potential benefits of these medications, such as Xeljanz and Rinvoq, while also addressing safety concerns related to cardiovascular risks and malignancies as outlined in the ORAL Surveillance study. |
| قاعدة البيانات: |
Academic Search Index |